Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-carnitine Supplementation in PCOS Patients Undergoing IVF/ICSI
NCT04672720Completed
- Sponsor
- Royan Institute
- Start
- Mar 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in polycystic ovary syndrome (PCOS) comparing L-carnitine Group with Placebo Group (2 arms). Primary endpoint: Oocyte maturity rate. Started Mar 2020; status: completed.
02
Drugs
levocarnitine
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT04672720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04672720.